CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-08 | BUCHI J KEVIN Director | Grant or award · Stock Option (right to buy) | +146,190 | 146,190 | ||
| 2020-07-20 | Huang James Director | Grant or award · Stock Option (right to buy) | +119,178 | 119,178 | ||
| 2020-01-29 | Shukla Sath EVP, Chief Financial Officer | Grant or award | +80,500 | 80,500 | ||
| 2020-01-29 | Shukla Sath EVP, Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +123,900 | 123,900 | ||
| 2020-01-29 | MAUNEY DAVID M MD President | Grant or award | +80,500 | 275,778 | ||
| 2020-01-29 | MAUNEY DAVID M MD President | Grant or award · Employee Stock Option (right to buy) | +123,900 | 123,900 | ||
| 2020-01-29 | Lafond Kevin G SVP, Treasurer & CAO | Grant or award | +18,000 | 81,985 | ||
| 2020-01-29 | Hadfield Robert General Counsel and Secretary | Grant or award | +59,100 | 159,819 | ||
| 2020-01-29 | Hadfield Robert General Counsel and Secretary | Grant or award · Employee Stock Option (right to buy) | +90,800 | 90,800 | ||
| 2020-01-29 | De Groot Eleanor EVP, GM Cell Therapy | Grant or award | +53,700 | 228,033 | ||
| 2020-01-29 | De Groot Eleanor EVP, GM Cell Therapy | Grant or award · Employee Stock Option (right to buy) | +82,600 | 82,600 | ||
| 2020-01-29 | Cooper Laurence James Neil Chief Executive Officer | Grant or award | +171,700 | 1,904,973 | ||
| 2020-01-29 | Cooper Laurence James Neil Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +264,200 | 264,200 | ||
| 2020-01-29 | Buck Jill EVP, GM Gene Therapy | Grant or award | +53,700 | 227,410 | ||
| 2020-01-29 | Buck Jill EVP, GM Gene Therapy | Grant or award · Employee Stock Option (right to buy) | +82,600 | 82,600 | ||
| 2020-01-02 | MAUNEY DAVID M MD President | Sale | −22,394 | $4.55 | $102K | 195,278 |
| 2020-01-02 | Lafond Kevin G SVP, Treasurer & CAO | Sale | −21,570 | $4.55 | $98K | 63,985 |
| 2020-01-02 | Hadfield Robert General Counsel and Secretary | Sale | −16,853 | $4.55 | $77K | 100,719 |
| 2020-01-02 | De Groot Eleanor EVP, GM Cell Therapy | Sale | −24,890 | $4.55 | $113K | 174,333 |
| 2020-01-02 | Buck Jill EVP, GM Gene Therapy | Sale | −27,923 | $4.55 | $127K | 173,710 |
Page 8 of 16 · 304 trades